Active Acne or Acne Scars? Stop Asking One Laser to Treat Two Different Problems

Acne and acne scars share a name and very little else from a procedural standpoint.

Active acne is an inflammatory skin disease. Acne scars are structural changes left after inflammation and healing. A laser designed to influence sebaceous glands is not doing the same job as fractional CO₂ resurfacing. A red-light acne device is not a scar treatment. RF microneedling used for scars is not automatically the answer to active cystic breakouts.

If a treatment menu puts all of this under “acne laser,” make it get more specific.

Active acne: the goal is to change the disease process

Light and laser treatments for active acne have pursued several targets: Cutibacterium acnes-related pathways, inflammation, vascular components and sebaceous glands. Modalities have included blue and red visible light, photodynamic therapy, IPL, PDL, infrared lasers and newer 1726-nm lasers designed to target sebaceous glands.

The American Academy of Dermatology notes that light and laser treatments can reduce acne for some patients but usually do not clear acne by themselves. Different devices target different lesion types, and combination treatment remains common.

1726-nm acne lasers are one of the more interesting newer categories

The 1726-nm wavelength is designed around selective heating of sebaceous glands. That makes the mechanism different from the older consumer idea of “blue light kills acne bacteria.”

Research on 1726-nm systems has expanded quickly. A 2026 systematic review examined efficacy and adverse events of laser treatments for acne across diverse skin types, and two-year real-world outcomes for a 1726-nm platform were published in July 2026. This is a category worth watching because it targets a biologically relevant structure and has growing follow-up data.

It is still not permission to convert “FDA cleared” into “best acne treatment for everyone.” Acne phenotype, severity, medication history, scarring risk, skin tone, cost and the strength of comparative evidence all matter.

Photodynamic therapy is more treatment than “blue light facial”

Photodynamic therapy combines a photosensitizing agent with light activation. Depending on the protocol, it can produce meaningful inflammation, photosensitivity and recovery requirements. The AAD specifically notes that after some forms of PDT patients must avoid sunlight for a defined period.

A 2025 systematic review of PDT for acne included thousands of participants across dozens of studies and found clinically relevant benefit, but the literature remains heterogeneous in sensitizers, light sources, protocols and outcome measures.

That makes PDT a real medical-aesthetic treatment category—not a spa add-on that should be sold as “extra glow while we are here.”

Acne scars: first identify the architecture

Once acne is controlled, the procedural question changes from stopping lesions to remodeling scars.

The AAD emphasizes that ice-pick, rolling, boxcar, raised and keloid scars require different approaches. Many patients have more than one scar type. That is why an acne-scar plan often combines procedures.

A rolling scar tethered by fibrous bands may need subcision. Deep ice-pick scars may respond to focal techniques. Broader boxcar or textural scarring may benefit from fractional resurfacing. Raised scars require an entirely different strategy.

Fractional CO₂ can remodel scars; it cannot untether everything

Fractional CO₂ remains one of the strongest-established laser options for atrophic acne scarring, but a laser can only remodel what its mechanism can reach. Deep tethering may limit how much surface resurfacing can accomplish on its own.

Recent meta-analyses continue to show that ablative fractional approaches can produce meaningful scar improvement, with a larger downtime and adverse-effect burden than many nonablative options.

The practical question is not “Does CO₂ work?” It is “What portion of my scar pattern is CO₂ expected to change, and what will remain?”

RF microneedling is a scar option with a newly louder risk conversation

A 2025 systematic review of fractional RF microneedling for acne scars included 16 studies and 481 patients and concluded that the treatment is likely effective as monotherapy, while calling for better randomized trials to establish parameters.

That evidence now sits beside the FDA’s October 2025 safety communication reporting serious complications with certain uses of RF microneedling, including burns, scarring, fat loss, disfigurement and nerve damage.

Both facts can be true: a procedure can have evidence of benefit and still demand more careful risk discussion.

Microneedling without RF remains relevant

Conventional microneedling induces controlled mechanical injury and collagen remodeling without adding RF energy. The AAD notes it can be used across skin tones and may be combined with other scar treatments.

For some patients, that may offer a different balance of cost, downtime, pigment risk and expected improvement. “More technology” is not automatically the same as a better scar plan.

Scar color and scar depth are different treatment problems

Red post-acne marks, brown PIH and true depressed scars can coexist. Treating them as one “scar” problem encourages confusion.

• Redness: may involve vascular-targeted approaches in selected cases.
• Brown PIH: pigment management and sun protection; energy treatment requires caution.
• Depressed scars: structural remodeling, subcision, resurfacing, needling, fillers or combinations.
• Raised scars/keloids: a different treatment family entirely.

A perfect laser for redness will not lift a tethered rolling scar. A fractional resurfacing laser may improve texture without erasing residual pigment.

Control active acne before polishing the evidence of old acne

The AAD advises that active breakouts are generally treated before scar procedures so new inflammation is not continuing to create scars during the correction process.

This is also where acne lasers should be judged against ordinary acne treatment, not only against doing nothing. A device may be useful for someone who cannot tolerate, does not respond to, or wants to reduce reliance on certain conventional options. That is different from claiming technology should automatically replace topical or systemic treatment.

Questions that force the plan to separate acne from scars

• Are we treating active acne, redness/pigment, scars, or more than one of these?
• If active acne: what lesion type or biological target is this device intended to affect?
• If scars: which scar types do I have?
• Does any tethering need subcision or another procedure before resurfacing?
• Why this device rather than conventional microneedling, fractional laser, RF microneedling, medication or another option?
• How does my skin tone change pigment risk?
• What improvement is realistic after the full course?
• What is the plan to prevent new acne scars while treating old ones?

The Verdict

“Acne laser” is an inadequate category.

Active acne treatment is trying to change an ongoing disease process. Acne-scar treatment is trying to remodel the architecture left behind. The same person may need both at different times, but the goals, evidence and device logic should never be blurred into one package.

This is general education and does not replace diagnosis or individualized acne treatment.